Showing 1 - 5 results of 5 for search 'Jan Budczies', query time: 0.01s Refine Results
  1. 1
    CG>TG mutation frequency as negative predictor of homologous recombination deficiency in ovarian and breast cancer

    CG>TG mutation frequency as negative predictor of homologous recombination deficiency in ovarian and breast cancer by Eva Romanovsky, Michael Menzel, Klaus Kluck, Susanne Beck, Markus Ball, Peter Schirmacher, Daniel Kazdal, Albrecht Stenzinger, Jan Budczies

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Contribution of genetics to hematopoietic stem cell mobilization: a genome-wide association study of 564 healthy donors mobilized with granulocyte colony-stimulating factor

    Contribution of genetics to hematopoietic stem cell mobilization: a genome-wide association study of 564 healthy donors mobilized with granulocyte colony-stimulating factor by Miriam Stenzinger, Susanne Beck, Iordanis Ourailidis, Anna-Lena Volckmar, Nagarajan Paramasivam, Aysel Ahadova, Aitzkoa Lopez de Lapuente Portilla, Phuong La Yen, Bjorn Nilsson, Justo Lorenzo Bermejo, Halvard Bonig, Jan Budczies

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Differentiating Main-Duct IPMN from Chronic Pancreatitis Using Next-Generation Sequencing of Main Pancreatic Duct Fluid: A Pilot Study

    Differentiating Main-Duct IPMN from Chronic Pancreatitis Using Next-Generation Sequencing of Main Pancreatic Duct Fluid: A Pilot Study by Daniel Schmitz, Stefan Prax, Martin Kliment, Felix Gocke, Daniel Kazdal, Michael Allgäuer, Roland Penzel, Martina Kirchner, Olaf Neumann, Holger Sültmann, Jan Budczies, Peter Schirmacher, Frank Bergmann, Jörg-Peter Ritz, Raoul Hinze, Felix Grassmann, Jochen Rudi, Albrecht Stenzinger, Anna-Lena Volckmar

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    An immune responsive tumor microenvironment imprints into PBMCs and predicts outcome in advanced pancreatic cancer: lessons from the PREDICT trial

    An immune responsive tumor microenvironment imprints into PBMCs and predicts outcome in advanced pancreatic cancer: lessons from the PREDICT trial by Anton Lahusen, Manfred P. Lutz, Rui Fang, Martina Kirchner, Sarah Albus, Klaus Kluck, Meinolf Karthaus, Andreas Schwarzer, Gabriele Siegler, Alexander Kleger, Thomas J. Ettrich, Alexander Becher, Sabine Höfling, Jens T. Siveke, Jan Budczies, Andrea Tannapfel, Albrecht Stenzinger, Phyllis Fung-Yi Cheung, Tim Eiseler, Thomas Seufferlein

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    EGFR-mediated local invasiveness and response to Cetuximab in head and neck cancer

    EGFR-mediated local invasiveness and response to Cetuximab in head and neck cancer by Jiefu Zhou, Min He, Qiong Zhao, Enxian Shi, Hairong Wang, Vaidehi Ponkshe, Jiahang Song, Zhengquan Wu, Dongmei Ji, Gisela Kranz, Anna Tscherne, Sabina Schwenk-Zieger, Nilofer Abdul Razak, Julia Hess, Claus Belka, Horst Zitzelsberger, Iordanis Ourailidis, Fabian Stögbauer, Melanie Boxberg, Jan Budczies, Christoph A. Reichel, Martin Canis, Philipp Baumeister, Hongxia Wang, Kristian Unger, Andreas Mock, Olivier Gires

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: